Filing Details
- Accession Number:
- 0001181431-13-029059
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-20 16:27:08
- Reporting Period:
- 2013-05-17
- Filing Date:
- 2013-05-20
- Accepted Time:
- 2013-05-20 16:27:08
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267602 | Alimera Sciences Inc | ALIM | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1489532 | David Holland | 6120 Windward Parkway Suite 290 Alpharetta GA 30005 | Svp Of Sales & Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-05-17 | 30,000 | $4.13 | 98,362 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.08 to $4.291, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- Includes 1,996 shares of common stock acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan on April 30, 2013.
Billionaire Hedge Funds
